Michelle Milliken
Articles by Michelle Milliken
Education Level, History of Brain Injury Linked with Frontotemporal Dementia Risk
Frontotemporal dementia tends to impact younger people than other forms of dementia do. While genetics is often at play, two new studies investigated other potential risk factors.
Education Level, History of Brain Injury Linked with Frontotemporal Dementia Risk
Frontotemporal dementia tends to impact younger people than other forms of dementia do. While genetics is often at play, two new studies investigated other potential risk factors.
Could a Beer Ingredient Guard Against Alzheimer's? A New Study Finds it Might
Hop flowers may not just give beer some flavor. A new study finds their compounds could also be protective against Alzheimer's.
Could a Beer Ingredient Guard Against Alzheimer's? A New Study Finds it Might
Hop flowers may not just give beer some flavor. A new study finds their compounds could also be protective against Alzheimer's.
Federal Wildlife Officials Looking Into Restoring Grizzly Bears to the North Cascades
Grizzly bears once thrived in the North Cascades, but it's been more than 25 years since a grizzly sighting has been confirmed there. Federal wildlife officials are looking into changing...
Federal Wildlife Officials Looking Into Restoring Grizzly Bears to the North Cascades
Grizzly bears once thrived in the North Cascades, but it's been more than 25 years since a grizzly sighting has been confirmed there. Federal wildlife officials are looking into changing...
Aerobic Exercise May Lower Risk of Metastatic Cancer By Up to 72%
Exercise has plenty of health benefits for everyone, including cancer survivors. A new study finds that a particular type of exercise may also substantially lower the risk of metastatic disease.
Aerobic Exercise May Lower Risk of Metastatic Cancer By Up to 72%
Exercise has plenty of health benefits for everyone, including cancer survivors. A new study finds that a particular type of exercise may also substantially lower the risk of metastatic disease.
Roche's Alzheimer's Drug Doesn't Meet Goals in Trials
The monoclonal antibody gantenerumab was tested over two years in two recent trials, but it was not found to slow clinical decline in early stage Alzheimer's patients.
Roche's Alzheimer's Drug Doesn't Meet Goals in Trials
The monoclonal antibody gantenerumab was tested over two years in two recent trials, but it was not found to slow clinical decline in early stage Alzheimer's patients.
Once Crammed in a Car with Multiple Other Birds, Sweet Cockatiel Now Has a Home, and a Girlfriend
Forrest has some differences, including feather loss, an atypical beak, and a missing section of toe. None of that slows him down from seeking head scratches or the love of...
Once Crammed in a Car with Multiple Other Birds, Sweet Cockatiel Now Has a Home, and a Girlfriend
Forrest has some differences, including feather loss, an atypical beak, and a missing section of toe. None of that slows him down from seeking head scratches or the love of...